Empagduo Tablet 5/500 mg
Empagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.
MFDS item code 202201392 · Approved 2022.04.04
Improvement of glycemic control in adults with type 2 diabetes
This medication is used in adults with type 2 diabetes to assist in improving blood sugar control in conjunction with dietary and exercise therapy. It is especially important to consult a healthcare professional in patients with cardiovascular disease who do not achieve satisfactory blood sugar control. This medication effectively supports diabetes treatment by aiding in blood sugar management.
The recommended dose of this drug is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other drugs such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose of 10 mg) and the patient's current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this drug from combination therapy with empagliflozin (total daily dose of 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this drug is administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see sections 4. Adverse Reactions and 6. Interactions under Precautions for Use). This drug should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this drug, take it as soon as you remember. However, do not take a double dose at one time; if this happens, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is required for patients with mild renal impairment. Because this drug contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual single-ingredient products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this drug is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see section 3. Patients Requiring Caution, item 1 under Precautions for Use). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this drug should be discontinued immediately (see section 2. Patients Who Must Not Take This Drug, item 2 under Precautions for Use). Elderly Patients For patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication can cause a rare but serious side effect called lactic acidosis. Lactic acidosis occurs when there is an excessive buildup of lactate in the body, which may present with symptoms such as difficulty breathing, muscle pain, malaise, and abdominal pain. Additionally, this medication may increase the risk of hypoglycemia when taken in combination with other diabetes drugs, so blood sugar levels should be monitored frequently. This medication should not be used in patients with severely impaired kidney function, acute kidney problems, severe infections, or those with unstable heart conditions. Patients receiving iodinated contrast agents used in radiological studies should temporarily suspend this medication before and after the examination and resume only after kidney function has returned to normal. Pregnant or nursing women should not take this medication, and women who may become pregnant should also avoid it. This medication can cause fluid loss, so caution is advised in cases of dehydration symptoms, diarrhea, or vomiting. Regular monitoring of kidney function, blood sugar, and vitamin B12 levels is necessary while on this medication. This medication may increase the risk of genital infections and urinary tract infections, so any signs of infection should lead to immediate consultation with a physician. The elderly, malnourished patients, and those who consume excessive alcohol should be particularly cautious due to increased risks of hypoglycemia and lactic acidosis. Patients undergoing surgery should stop this medication 48 hours before the procedure and only resume after kidney function has returned to normal following the surgery. During the course of treatment, symptoms of hypoglycemia and lactic acidosis should be carefully monitored, and any abnormal symptoms should be reported to healthcare personnel immediately. Also, caution is necessary when driving or operating machinery, so the patient's condition should be assessed thoroughly. In case of overdose, it is essential to visit a hospital immediately for appropriate treatment, especially if symptoms of lactic acidosis occur, which require prompt intervention. This medication is not recommended for children and should be stored out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The recommended storage temperature is room temperature between 1 and 30 degrees Celsius. This will help maintain the effectiveness and safety of the medication for a long time.
Orange-yellow, bilaterally convex oval film-coated tablet
10 tablets/box [10/PTP X 1], 60 tablets/box [10/PTP X 6], 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.